FTM
RCKT icon

First Turn Management’s Rocket Pharmaceuticals RCKT Stock Holding History

First Turn Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-621,306
Closed -$11.5M – 41
2024
Q3 		$11.5M Buy
621,306
+60,317
+11% +$1.24M 1.82% 34
2024
Q2 		$12.1M Buy
560,989
+310,119
+124% +$7.12M 1.96% 29
2024
Q1 		$6.76M Buy
+250,870
New +$7.13M 1.01% 32

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Turn Management's RCKT Position: Q4 2024 in Review

First Turn Management sold out of Rocket Pharmaceuticals (RCKT) in Q4 2024, closing a stake of 621,306 shares — an estimated $11.5M sold.

First Turn Management first reported a position in RCKT in Q1 2024 and held it in 3 quarters. The position peaked at $12.1M in Q2 2024. 225 funds tracked by Wall St. Rank hold RCKT as of Q4 2024.

  • First Turn Management reported no remaining Rocket Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • First Turn Management sold 621,306 Rocket Pharmaceuticals shares in Q4 2024, an estimated $11.5M.
  • First Turn Management first reported a position in Rocket Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • First Turn Management's Rocket Pharmaceuticals position peaked at $12.1M in Q2 2024.
  • 225 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q4 2024.

Based on First Turn Management's 13F filing for Q4 2024, filed 14 Feb 2025.